Education Sessions
E-IP1a & b; E-IP2a, b, & c
Innovation and Strategic Partnerships in
Investigational Products (IP): A Winning
Combination
(Four Successive Sessions)
| 5 November 13.15-17.00 6 November 08.15-11.30 6 November 14.15-17.30 7 November 09.00-12.00 |
Track: Investigational Products |
Bayfront Medical Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmaceutical education. Bayfront Medical Center designates this educational activity for a maximum of 9.75 contact hours. This activity requires a maximum registration fee of $1700.00. Each participant should claim only those hours of credit for which an evaluation form has been completed. Bayfront Medical Center will issue statements of credit no later than 30 days after completion. Universal Program Number: 298-999-07-016-L04-P.
Interact and gain real world insight, based on the experiences of your peers, that prepare you for the challenges of tomorrow by participating in a truly global Investigational Products (IP) program. Share in the discussion of innovative solutions to IP challenges offered by your industry colleagues from all segments of the pharmaceutical industry.
The ISPE Investigational Products Community of Practice (IP COP) is a unique global organization with a common global strategic vision that supports industry professionals worldwide by providing relevant, timely, and cutting-edge information and services, and access to solutions and resources to industry professionals with interest or professional experience in all aspects of the investigational products supply chain. Through its educational programs, publications, and outreach to industry and regulatory professionals, the IP COP is an important advocate of IPs and their importance in the drug approval process.
At the ISPE 2007 Annual Meeting, the IP COP brings together industry professionals for interactive learning and networking opportunities. The educational forum kicks off with a half-day session. Attendees choose one of two professional tracks for an interactive and focused workshop experience. Participants in both workshops have the opportunity to discuss their own challenges in these areas and takeaway actionable solutions.
The workshops are followed by a one and a half-day forum that includes presentations, as well as breakout sessions that discuss and offer solutions to current IP hot topics. This series focuses on innovation and strategic partnerships.
Take Back to Your Job
- Implement new ideas and trends in supply chain forecasting and planning, and foster innovation in your organization
- Form effective partnerships and know best practices when working with internal and external customers
- Know about the latest on retest date labeling in Europe
- Gain industry and peer perspective on managing phase IV and investigator initiated trial supply challenges
Agenda
Monday, 5 November
IP Interactive Workshops
Choose one of two professional tracks for your
interactive and focused workshop experience:
Track 1: What’s New in Clinical Supplies Forecasting and Planning? Participate in case studies describing the challenges of clinical supplies forecasting and planning, and offer practical solutions.
Track 2: How to Improve Customer Service Levels – Delivering the right IP at the right time is addressed from the customer’s perspective.
Tuesday, 6 November – Wednesday, 7 November
Innovation and Strategic Partnerships in
Investigational Products: A Winning Combination
Increase your ability to deliver today and tomorrow. This
series focuses on innovation and strategic partnerships.
The program includes presentations on Innovation inR&D, an IP Solution through successful partnering,
China’s distribution channels, forensic science, and an
update on current legal issues facing IP. The breakout
sessions provide an ideal setting for delegates to
discuss current hot topics in smaller groups with other
industry colleagues.
ACPE CEUs are awarded for these sessions. Application for these credits is pending.
Who Should Attend
Investigational Products professionals from all levels of the pharmaceutical and biotechnology industry with a desire to minimize risk and expand their knowledge and understanding of solutions to current and emerging challenges in our global and dynamic R&D environment.
Community of Practice: Investigational Products (IP)
Session Leaders
- Kristen DeVito, Director, Project Mgmt, Aptuit, Inc.
- Michelle Foust, Director, New Product Dev, Almac Clinical Services
- Julie Jacobs, Director Clinical Services, ALMAC
- Kunal Jaiswal, Director, Global Clinical Supply, Schering-Plough Corporation
- Michael Ku, Sr Dir, Clinical Pharma Svcs, Genzyme Corp
- Paula Mastrangelo, Associate Director, Bristol-Myers Squibb
- Christine Milligan, Director, Client Services, Fisher Clinical Services Inc
- Bernd Steffens, Global Head Clinical Trial Supplies Unit, Boehringer Ingelheim Pharma GmbH & Co
- Michael Sweeney, Global Director, Strategic Development, World Courier, Inc.
Session Speakers
- Chedia Abdelkafi, Sr Consultant, CT Supply Chain, N-Side
- Dale Aldrich, President, Ultramikro, LLC
- Michael Arnold, Bus. Process Head, GSC, Pfizer Inc
- Dave Asher, CEO & President, Asher Associates Inc.
- Sandra Cook, Supply Chain Project Mgr, AstraZeneca
- Patricia Dimock, Packaging Coordinator, Pfizer Inc
- Kathleen Eddeh, Clinical Demand Project Mgr, Schering Plough Corporation
- Evelyn Ego, Head Global Clinical Supply, Bayer Schering Pharma AG
- Christine Fattore, Dir, Clin.Research Pharma, MedImmune
- Miguel Feliz, Senior Clinical Supplies Manager, Schering-Plough Corp
- Dan Giang, Clinical Trials Pharmacist, Almac Clinical Services
- Mitchell Horoho, CT Materials Associate, Eli Lilly & Co
- Vickie Johnson, Clinical Trials Pharmacist, Almac Clinical Services
- Angus MacLeod, Global Depot Manager, Aptuit
- Linda Manor, Pharmacist, University of North Carolina Hospitals
- Michael McNear, VP Client Services, Fisher Clinical Services
- Alan Minsk, Partner & Leader, Food & Drug Practice Team, Arnall Golden & Gregory LLP
- Robert Pizzie, Sr Director, GCS Planning, Schering-Plough
- Chris Popple, Mgr. Clinical Demand Planning, MedImmune, Inc.
- Benjamin Romero, Principal Packaging Engineer, Bristol-Myers Squibb
- Robert Smith, Dir CPRS QA & QP, Genzyme Ltd
- Peter Trimboli, Drug Supply Manager, Bristol-Myers Squibb
